|
|
Volumn 15, Issue 12, 2001, Pages 955-968
|
|
Future prospects for the drug treatment of epilepsy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (4 CHLOROPHENYL) 4,5 DIHYDRO 5 (4 PYRIDYL) 1H 1,2,3 TRIAZOLE;
AMINO ACID RECEPTOR BLOCKING AGENT;
ANTICONVULSIVE AGENT;
BARBITURIC ACID DERIVATIVE;
BIA 2093;
CARABERSAT;
CARBAMAZEPINE;
ETIRACETAM;
FELBAMATE;
GABAPENTIN;
GANAXOLONE;
GLUTAMATE RECEPTOR ANTAGONIST;
HARKOSERIDE;
LAMOTRIGINE;
LOSIGAMONE;
MDL 27192;
OXCARBAZEPINE;
PHENYTOIN;
PREGABALIN;
RETIGABINE;
SAFINAMIDE;
SODIUM CHANNEL BLOCKING AGENT;
TALAMPANEL;
TIAGABINE;
TOPIRAMATE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALPROIC ACID;
VALROCEMIDE;
VIGABATRIN;
ZONISAMIDE;
ANTICONVULSANT ACTIVITY;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
EPILEPSY;
HUMAN;
LICENSING;
NEUROTRANSMISSION;
PRIORITY JOURNAL;
REVIEW;
|
|
EID: 0035667269
PISSN: 11727047
EISSN: None
Source Type: Journal
DOI: 10.2165/00023210-200115120-00005 Document Type: Review |
|
Times cited : (30)
|
|
References (5)
|
